Investigation of biomarkers for predicting effectiveness of treatments for Crohn's disease

Investigation of biomarkers for predicting effectiveness of treatments for Crohn's disease - Biomarkers of Crohn's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002341

Enrollment

100

Registered

2009-08-18

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Crohn's disease elder than 16 years old who need treatments with Infliximab and gave written informed consent.

Exclusion criteria

Exclusion criteria: Patients with Crohn's disease who are not applicable to Infliximab treatment and who do not give written informed consent.

Design outcomes

Primary

Measure	Time frame
Analysis of 50 cytokines by multiplex array system and clinica activity of Crohn's disease	—

Countries

Japan

Contacts

Public ContactHideki Iijima

Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology

hiijima@gh.med.osaka-u.ac.jp+81-6-6879-3621

Outcome results